Description of an efficacious behavioral peer-driven intervention to reduce racial/ethnic disparities in AIDS clinical trials

AIDS clinical trials (ACTs) are critical to the development of new treatments for HIV infection. However, people of color living with HIV/AIDS are involved in ACTs at disproportionally low rates, with African-Americans experiencing the greatest under-representation. In this article, we describe the...

Full description

Saved in:
Bibliographic Details
Published inHealth education research Vol. 28; no. 4; pp. 574 - 590
Main Authors Leonard, N. R., Banfield, A., Riedel, M., Ritchie, A. S., Mildvan, D., Arredondo, G., Cleland, C. M., Gwadz, M. V.
Format Journal Article
LanguageEnglish
Published England Oxford University Press 01.08.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:AIDS clinical trials (ACTs) are critical to the development of new treatments for HIV infection. However, people of color living with HIV/AIDS are involved in ACTs at disproportionally low rates, with African-Americans experiencing the greatest under-representation. In this article, we describe the core elements and key characteristics of a highly efficacious multi-component peerdriven intervention (PDI) designed to increase rates of screening for and enrollment into ACTs among African-American and Latino/Hispanic individuals, by addressing the main complex, multi-level barriers they experience to ACTs. We discuss the process of developing the intervention, the theoretical models guiding its delivery format and content, and provide an overview of the intervention's components. We then use brief case studies to illustrate a number of key issues that may arise during intervention implementation. Finally, we describe lessons learned and provide recommendations for the PDI's uptake in clinical and clinical trials settings.
Bibliography:ObjectType-Case Study-3
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-2
ObjectType-Article-2
ObjectType-Feature-1
ObjectType-Feature-2
ISSN:0268-1153
1465-3648
DOI:10.1093/her/cyt052